- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05309265
Vocational Rehabilitation for the Return to Work of Breast Cancer Patients: a Feasibility Study (VocRehab)
Multidisciplinary Vocational Rehabilitation Intervention to Support the Return to Work of Breast Cancer Patients: a Feasibility Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
BC is a public health burden with increasing trends in Western countries. In Italy, 50% of the new BC diagnosis have occurred in female of working age. Even though the return to work (RTW) is strongly desired, cancer survivors are 1.4 times more likely to be unemployed than healthy individuals. Furthermore, work difficulties may occur during this process. To promote the RTW, multidisciplinary interventions have shown moderate quality evidence in cancer survivors.
Since 2018, the investigators have planned a local social-healthcare pathway which provides a multidisciplinary vocational rehabilitation intervention with the aim to help cancer survivors in their RTW process. During the implementation of the pathway, BC patients were referred mainly by the physiotherapists of the Physical Medicine and Rehabilitation Unit (PMRU). As standard care, BC patients can participate to an educational group session held by the physiotherapists after surgery. During this session, work difficulties have emerged.
Thus, the investigators aim to verify the feasibility of the multidisciplinary vocational rehabilitation intervention for a sample of BC patients whit work difficulties who will participate to an educational group session held by the physiotherapists.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Sara Paltrinieri, Msc OT
- Phone Number: 0039 3477825250
- Email: sara.paltrinieri@ausl.re.it
Study Contact Backup
- Name: Stefania Costi, PhD
- Phone Number: 0039 0522 522441
- Email: stefania.costi@unimore.it
Study Locations
-
-
-
Reggio Emilia, Italy, 42123
- Recruiting
- Azienda Unità Sanitaria Locale Reggio Emilia
-
Contact:
- Sara Paltrinieri, Msc OT
- Phone Number: 00390522522416
- Email: sara.paltrinieri@ausl.re.it
-
Contact:
- Stefania Costi, PhD
- Phone Number: 00390522522441
- Email: stefania.costi@unimore.it
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- breast cancer diagnosis (regardless of stage and treatment)
- breast cancer patients in working age
- breast cancer patient who will participate to an educational group session held by the physiotherapists of the PMRU
- breast cancer patients with work difficulties
Exclusion Criteria:
- Breast cancer patients with work issues that cannot be addressed by any of the interventions (e.g., patients who would like to change their job)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Breast cancer patients with work difficulties
Breast cancer patients with work difficulties can receive any of the three types of support, or a combination of these: information, occupational therapy and social support, in order to overcome barriers and return to work/continue to work
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
interception
Time Frame: 12 months
|
rate of patients who has been proposed to participate to the feasibility study
|
12 months
|
acceptation
Time Frame: 12 months
|
rate of patients (who has been proposed to participate to the feasibility study) who accept to participate
|
12 months
|
adherence
Time Frame: 12 months
|
rate of patients who participate in the scheduled meeting and in the multidisciplinary intervention proposed; rate of patients who agree to receive the intervention at the workplace (for those eligible)
|
12 months
|
lost to follow-up
Time Frame: 12 months
|
rate of patients who will not attend the scheduled meeting (drop-out rate set ≤ 20%)
|
12 months
|
satisfaction rate
Time Frame: 12 months
|
rate of patients who perceive the modules of the multidisciplinary intervention as supportive for their RTW or work continuation
|
12 months
|
RTW/work continuation
Time Frame: 12 months
|
rate of patients who participate in the study and who will RTW or continued to work
|
12 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Sara Paltrinieri, Msc OT, Azienda Unità Sanitaria Locale Reggio Emilia
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022/0035986
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of WashingtonTerminatedBreast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Breast Cancer Stage IIB | Breast Cancer Stage IIA | Breast Cancer Stage IIIA | Breast Cancer Stage IIIB | Breast Cancer Stage IIIcUnited States
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast...United States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Susan G. Komen Breast Cancer FoundationCompletedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer
Clinical Trials on Multidisciplinary vocational rehabilitation intervention
-
Brain Injury Center BOMI, Roskilde, DenmarkRigshospitalet, Denmark; University of Copenhagen; Hospital de CrucesUnknown
-
Boston UniversityU.S. Department of EducationUnknownArthritisUnited States
-
SanoCompleted
-
Vardalinstitutet The Swedish Institute for Health...Unknown
-
VA Office of Research and DevelopmentCompletedSpinal Cord InjuriesUnited States
-
Tuscaloosa Research & Education Advancement CorporationUnited States Department of DefenseUnknown
-
LHL HelseCompletedChronic Obstructive Pulmonary Disease | AsthmaNorway
-
Mental Health Services in the Capital Region, DenmarkCopenhagen Municipality, Denmark; Municipality of Lyngby-Taarbæk, Denmark; Gladsaxe... and other collaboratorsCompletedBurnout | Adjustment Disorder | Psychological StressDenmark
-
Hacettepe UniversityBiruni UniversityCompleted
-
Mental Health Services in the Capital Region, DenmarkCopenhagen Municipality, Denmark; Municipality of Lyngby-Taarbæk, Denmark; Gladsaxe... and other collaboratorsCompletedDepression | Panic Disorder | Social Phobia | Generalized AnxietyDenmark